KN
Krishanamoorthy Nirosha
About Krishanamoorthy Nirosha
Data last updated:
Krishanamoorthy Nirosha is a Whole-Time Director at Regenix Drugs Limited (since 2021) and Cfo at Regenix Biosciences Limited (since 2019). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Regenix Drugs Limited at ₹188 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regenix Drugs Limited U24232TN2007PLC063446 | Whole-Time Director | 21 Jun 2021 | 2007 | ₹188 Cr (FY 2024) | Active |
 Regenix Biosciences Limited U24100TN2006PLC059065 | Cfo | 01 May 2019 | 2006 | ₹6.81 Cr (FY 2025) | Active |
Board colleagues of Krishanamoorthy Nirosha
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishanamoorthy Nirosha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishanamoorthy Nirosha
Krishanamoorthy Nirosha currently holds 2 directorships: Regenix Drugs Limited (Whole-Time Director, since 21 Jun 2021, revenue ₹188 Cr (FY 2024)); Regenix Biosciences Limited (Cfo, since 01 May 2019, revenue ₹6.81 Cr (FY 2025)).
Krishanamoorthy Nirosha was first appointed on 01 May 2019 as Cfo at Regenix Biosciences Limited. The most recent appointment on record is 21 Jun 2021 at Regenix Drugs Limited.
The 2 current companies of Krishanamoorthy Nirosha that report revenue have a combined latest revenue of ₹195 Cr: Regenix Drugs Limited ₹188 Cr (FY 2024); Regenix Biosciences Limited ₹6.81 Cr (FY 2025).
The current boards of Krishanamoorthy Nirosha's companies include Akshay Arvind (Regenix Drugs Limited), Ayyamperumal (Regenix Drugs Limited), Balaji Ramamurthy (Regenix Drugs Limited), Govindarajan Venkatakrishna (Regenix Drugs Limited), Guhan Ramamurthy (Regenix Drugs Limited), Gunasekaran Raju (Regenix Drugs Limited), among others.